You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 1, January 14, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Men's Health
 •Osteoporosis
 •Surgery
 •Orthopedic Surgery
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Endogenous Sex Hormones and Incident Fracture Risk in Older Men

The Dubbo Osteoporosis Epidemiology Study

Christian Meier, MD; Tuan V. Nguyen, PhD; David J. Handelsman, MBBS, PhD, FRACP; Christian Schindler, PhD; Mark M. Kushnir, PhD; Alan L. Rockwood, PhD; A. Wayne Meikle, MD; Jacqueline R. Center, MBBS, FRACP, PhD; John A. Eisman, MBBS, PhD, FRACP; Markus J. Seibel, MD, PhD, FRACP

Arch Intern Med. 2008;168(1):47-54.

Background  Data on the influence of gonadal hormones on incident fracture risk in elderly men are limited. We prospectively examined the relationship between serum levels of testosterone and estradiol and future fracture risk in community-dwelling men.

Methods  A total of 609 men older than 60 years had been observed between January 1989 and December 2005, with the median duration being 5.8 years (up to 13 years). Clinical risk factors, including bone mineral density and lifestyle factors, were assessed at baseline. Serum testosterone and estradiol levels were measured by tandem mass spectrometry. The incidence of a low-trauma fracture was ascertained during follow-up.

Results  During follow-up, 113 men had at least 1 low-trauma fracture. The risk of fracture was significantly increased in men with reduced testosterone levels (hazard ratio [HR], 1.33; 95% confidence interval [CI], 1.09-1.62). After adjustment for sex hormone–binding globulin, serum testosterone (HR, 1.48; 95% CI, 1.22-1.78) and serum estradiol (HR, 1.21; 95% CI, 1.00-1.47) levels were associated with overall fracture risk. After further adjustment for major risk factors of fractures (age, weight or bone mineral density, fracture history, smoking status, calcium intake, and sex hormone–binding globulin), lower testosterone was still associated with increased risk of fracture, particularly with hip (HR, 1.88; 95% CI, 1.24-2.82) and nonvertebral (HR, 1.32; 95% CI, 1.03-1.68) fractures.

Conclusion  In community-dwelling men older than 60 years, serum testosterone is independently associated with the risk of osteoporotic fracture and its measurement may provide additional clinical information for the assessment of fracture risk in elderly men.


Author Affiliations: Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Basel (Dr Meier), and Institute of Social and Preventive Medicine, University of Basel (Dr Schindler), Basel, Switzerland; Bone Research Program (Drs Meier and Seibel) and Department of Andrology (Dr Handelsman), ANZAC Research Institute, University of Sydney, Bone and Mineral Research Program, Garvan Institute of Medical Research, St Vincent's Hospital and University of New South Wales (Drs Nguyen, Center, and Eisman), Sydney, Australia; ARUP Institute for Clinical and Experimental Pathology (Drs Kushnir and Rockwood) and Departments of Pathology (Drs Rockwood and Meikle) and Medicine, University of Utah, Salt Lake City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The role of estrogens for male bone health
Ohlsson and Vandenput
Eur J Endocrinol 2009;160:883-889.
ABSTRACT | FULL TEXT  

Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
Wang et al.
J Androl 2009;30:1-9.
FULL TEXT  

Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants
Jankowska et al.
Eur J Heart Fail 2009;11:28-38.
ABSTRACT | FULL TEXT  

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations
Wang et al.
Eur J Endocrinol 2008;159:507-514.
FULL TEXT  

Men's Health, Low Testosterone, and Diabetes: Individualized Treatment and a Multidisciplinary Approach
Rice et al.
The Diabetes Educator 2008;34:97S-112S.
ABSTRACT | FULL TEXT  

Pathophysiology and Diagnosis of Osteoporosis in Aging Men
Szulc
IBMS BoneKEy 2008;5:370-380.
ABSTRACT | FULL TEXT  

Osteoporosis in Men
Khosla et al.
Endocr. Rev. 2008;29:441-464.
ABSTRACT | FULL TEXT  

Osteoporosis in Men
Ebeling
NEJM 2008;358:1474-1482.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.